258 related articles for article (PubMed ID: 26223969)
1. MicroRNA-181a, a potential diagnosis marker, alleviates acute graft versus host disease by regulating IFN-γ production.
Sang W; Zhang C; Zhang D; Wang Y; Sun C; Niu M; Sun X; Zhou C; Zeng L; Pan B; Chen W; Yan D; Zhu F; Wu Q; Cao J; Zhao K; Chen C; Li Z; Li D; Loughran TP; Xu K
Am J Hematol; 2015 Nov; 90(11):998-1007. PubMed ID: 26223969
[TBL] [Abstract][Full Text] [Related]
2. Serum microRNA181a: Correlates with the intracellular cytokine levels and a potential biomarker for acute graft-versus-host disease.
Xie L; Zhou F; Liu X; Fang Y; Yu Z; Song N; Kong F
Cytokine; 2016 Sep; 85():37-44. PubMed ID: 27288630
[TBL] [Abstract][Full Text] [Related]
3. Circulating miRNA panel for prediction of acute graft-versus-host disease in lymphoma patients undergoing matched unrelated hematopoietic stem cell transplantation.
Gimondi S; Dugo M; Vendramin A; Bermema A; Biancon G; Cavané A; Corradini P; Carniti C
Exp Hematol; 2016 Jul; 44(7):624-634.e1. PubMed ID: 27013207
[TBL] [Abstract][Full Text] [Related]
4. miR-181a Expression in Donor T Cells Modulates Graft-versus-Host Disease after Allogeneic Bone Marrow Transplantation.
Lee CW; Wohlan K; Dallmann I; Förster R; Ganser A; Krueger A; Scherr M; Eder M; Koenecke C
J Immunol; 2016 May; 196(9):3927-34. PubMed ID: 27009493
[TBL] [Abstract][Full Text] [Related]
5. miR-153-3p, a new bio-target, is involved in the pathogenesis of acute graft-versus-host disease via inhibition of indoleamine- 2,3-dioxygenase.
Zhao XS; Wang YN; Lv M; Kong Y; Luo HX; Ye XY; Wu Q; Zhao TF; Hu YH; Zhang HY; Huo MR; Wan J; Huang XJ
Oncotarget; 2016 Jul; 7(30):48321-48334. PubMed ID: 27340781
[TBL] [Abstract][Full Text] [Related]
6. Endothelial microparticles delivering microRNA-155 into T lymphocytes are involved in the initiation of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
Zhang R; Wang X; Hong M; Luo T; Zhao M; Shen H; Fang J; Li X; Zang S; Chen P; Nie D; Zheng P; Wu Q; Xia L
Oncotarget; 2017 Apr; 8(14):23360-23375. PubMed ID: 28423578
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between the IFN-gamma producing cells specific for recipient and acute graft versus host disease].
Meng XJ; Lin MF; Cai Z
Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):95-8. PubMed ID: 16732961
[TBL] [Abstract][Full Text] [Related]
8. Increased plasma indoleamine 2,3-dioxygenase activity and interferon-γ levels correlate with the severity of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Xu J; Wei J; Zhu X; Zhang X; Guan J; Wang J; Yin J; Xiao Y; Zhang Y
Biol Blood Marrow Transplant; 2013 Feb; 19(2):196-201. PubMed ID: 23089565
[TBL] [Abstract][Full Text] [Related]
9. Plasma microRNA signature as a noninvasive biomarker for acute graft-versus-host disease.
Xiao B; Wang Y; Li W; Baker M; Guo J; Corbet K; Tsalik EL; Li QJ; Palmer SM; Woods CW; Li Z; Chao NJ; He YW
Blood; 2013 Nov; 122(19):3365-75. PubMed ID: 24041574
[TBL] [Abstract][Full Text] [Related]
10. IL-17C Mitigates Murine Acute Graft-vs.-Host Disease by Promoting Intestinal Barrier Functions and Treg Differentiation.
Gong H; Ma S; Liu S; Liu Y; Jin Z; Zhu Y; Song Y; Lei L; Hu B; Mei Y; Liu H; Liu Y; Wu Y; Dong C; Xu Y; Wu D; Liu H
Front Immunol; 2018; 9():2724. PubMed ID: 30534126
[TBL] [Abstract][Full Text] [Related]
11. Plasma microRNA-586 is a new biomarker for acute graft-versus-host disease.
Wang Y; Zhao X; Ye X; Luo H; Zhao T; Diao Y; Zhang H; Lv M; Zhang W; Huang X; Wan J
Ann Hematol; 2015 Sep; 94(9):1505-14. PubMed ID: 26051902
[TBL] [Abstract][Full Text] [Related]
12. Three-dimensional structure discrepancy between HLA alleles for effective prediction of aGVHD severity and optimal selection of recipient-donor pairs: a proof-of-concept study.
Han H; Yuan F; Sun Y; Liu J; Liu S; Luo Y; Liang F; Liu N; Long J; Zhao X; Kong F; Xi Y
Oncotarget; 2015 Nov; 6(37):40337-59. PubMed ID: 26498683
[TBL] [Abstract][Full Text] [Related]
13. [Plasma MiR-181b and MiR-194 As Biomarkers for Acute Graft- Versus-Host Disease and Significance of Their Changes].
Chen Y; Deng HL; Kang DL; Wang Y; Hong XL; Lu QY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Jun; 29(3):957-962. PubMed ID: 34105500
[TBL] [Abstract][Full Text] [Related]
14. [Prophylactic effect of TLR5 agonist flagellin on acute graft versus host disease after allogeneic hematopoietic stem cell transplantation and its mechanism].
Gong XD; Ma LM; Zhu L; Guo HM; Ren LS; Ren RR; Zhang HP; Wei F; Niu YY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):965-70. PubMed ID: 22931665
[TBL] [Abstract][Full Text] [Related]
15. Angiogenic factors are associated with development of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Nie DM; Wu QL; Zhu XX; Zhang R; Zheng P; Fang J; You Y; Zhong ZD; Xia LH; Hong M
J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):694-699. PubMed ID: 26489624
[TBL] [Abstract][Full Text] [Related]
16. ADAR1 improved Treg cell function through the miR-21b/Foxp3 axis and inhibits the progression of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Zhao Y; Zheng X; Li M; Zhao J; Wang X; Zhu H
Int Immunopharmacol; 2023 Feb; 115():109620. PubMed ID: 36577155
[TBL] [Abstract][Full Text] [Related]
17. LYG1 Deficiency Attenuates the Severity of Acute Graft-Versus-Host Disease
Liu H; Yu Z; Tang B; Miao S; Qin C; Li Y; Liang Z; Shi Y; Zhang Y; Wang Q; Yan M; Song Z; Ren H; Dong Y
Front Immunol; 2021; 12():647894. PubMed ID: 34262560
[TBL] [Abstract][Full Text] [Related]
18. Saliva and blood interferon gamma levels and IFNG genotypes in acute graft-versus-host disease.
Resende RG; Correia-Silva JD; Silva TA; Xavier SG; Bittencourt H; Gomez RS; Abreu MH
Oral Dis; 2012 Nov; 18(8):816-22. PubMed ID: 22748084
[TBL] [Abstract][Full Text] [Related]
19. Serum microRNA155 is increased in patients with acute graft-versus-host disease.
Xie LN; Zhou F; Liu XM; Fang Y; Yu Z; Song NX; Kong FS
Clin Transplant; 2014 Mar; 28(3):314-23. PubMed ID: 24494749
[TBL] [Abstract][Full Text] [Related]
20. Serum miR-29a Is Upregulated in Acute Graft-versus-Host Disease and Activates Dendritic Cells through TLR Binding.
Ranganathan P; Ngankeu A; Zitzer NC; Leoncini P; Yu X; Casadei L; Challagundla K; Reichenbach DK; Garman S; Ruppert AS; Volinia S; Hofstetter J; Efebera YA; Devine SM; Blazar BR; Fabbri M; Garzon R
J Immunol; 2017 Mar; 198(6):2500-2512. PubMed ID: 28159900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
